Dian Diagnostics Group

Dian Diagnostics Group Co., Ltd. was established in 2001 as an independent third-party medical diagnostic service provider with a core business of offering diagnostic service outsourcing. With its unique "service + product" integrated business model, the company has become a pioneer and advocate in the industry. In July 2011, it became the first listed company in China's independent medical laboratory sector (stock code: 300244), achieving "zero breakthrough" for China’s independent medical laboratories in the stock market. Dian Diagnostics is committed to the mission of "enabling equal access to health for all Chinese people," and strives to provide customers with a "comprehensive solution for medical diagnostic services." The company actively promotes a multi-service expansion strategy for third-party independent medical diagnostic platforms, integrating upstream and downstream industrial chain development. Its businesses cover medical diagnostic services, diagnostic technology R&D, diagnostic product manufacturing and marketing, CRO, forensic identification, health management, cold chain logistics, and more. Currently, Dian Diagnostics operates 40 chain medical laboratories across China, serving over 20,000 medical institutions nationwide and having provided services to more than 300 million people cumulatively.